Journal Article Summary
The article investigates the relationship between early use of oral contraceptives and the risk of developing breast cancer. This topic is significant because understanding potential risk factors for breast cancer can help women make informed choices about their reproductive health. The study focuses on whether the duration of oral contraceptive use before a woman's first full-term pregnancy affects her likelihood of being diagnosed with breast cancer, particularly in younger women.
The researchers conducted a case-control study in London, Oxford, and Edinburgh from 1980 to 1984, involving 1,125 women aged 16 to 64 who were newly diagnosed with breast cancer, along with a matched group of controls. They found that among women aged 45 and older, there was no link between oral contraceptive use and breast cancer. However, for women under 45, those who used oral contraceptives for four or more years before their first full-term pregnancy had a significantly higher risk of breast cancer, with a relative risk of 2.6 compared to those who never used them.
The study has limitations, including potential biases and variations in the types of oral contraceptives used, which could affect the results. It is important for readers to understand that while this study suggests a possible increased risk for younger women, it contradicts findings from other research. Patients should discuss these findings with their healthcare professionals to weigh the risks and benefits of oral contraceptive use in the context of their individual health and family history.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- McPherson K., Vessey M. P., Neil A., Doll R., Jones L., Roberts M.. Early oral contraceptive use and breast cancer: results of another case-control study.. British Journal of Cancer 1987. DOI: 10.1038/bjc.1987.261. PMID: 3426932. PMCID: PMC2001913.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
